Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05159700 |
| Title | A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Zhuhai Yufan Biotechnologies Co., Ltd |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarah Cannon Research Institute at HealthONE | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Sarah Cannon Research Institute at Florida Cancer Specialists | RECRUITING | Orlando | Florida | 32827 | United States | Details |
| Christ Hospital | RECRUITING | Cincinnati | Ohio | 21073 | United States | Details |
| NEXT Oncology | RECRUITING | Austin | Texas | 73301 | United States | Details |
| Mays Cancer Center | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| NEXT Oncology | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |